Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
Special Seminar: Pathology in the Era of Precision Medicine with Prof. Johan Hartman
The iCANPOD postdoctoral program in precision cancer medicine at the University of Helsinki will be officially launched at its opening event on 26…
iCAN Science Seminar on The day after the drug – investigating cancer persister cells memory with Assist. Prof. Yaara Oren
Warm welcome to the iCAN Science Seminar with Assist. Prof. Yaara Oren (Tel Aviv University) on The day after the…
Mission Possible – Delivering translational impact
More than 360 participants: speakers, researchers, clinicians, patients, sponsors, and other cancer research specialists gathered in Little Finlandia (Helsinki) on…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
